Online Registration is Open!
Register by Friday, December 20, 2013 to Save Up to $450.
Printed from the IBC Life Sciences Web site on December 5, 2013 0:31 PM ET.
Page location: http://www.ibclifesciences.com/TIDES/speak.xml
May 12-15, 2014
Rhode Island Convention Center
If you are working in any of the following scientific/business topic areas, we encourage you to submit proposal for a podium presentation. Inclusion of case study data is highly recommended and coverage of discontinued projects with lessons learned would be very beneficial to this audience.
To submit a presentation for consideration, please click the corresponding link belowand provide a description of the proposed presentation's content by Friday, November 1, 2013.
If your talk is accepted, you will receive a formal invitation to speak at the conference. This invitation will reflect a deadline for you to send a final presentation title and 60-word abstract. Your abstract and presentation must describe scientific results and must not contain marketing or business development content.
If you would like to submit a proposal, but need an extension or have any topic suggestions, please contact Ellen King, Conference Producer, at firstname.lastname@example.org or Michael Keenan, Conference producer, at email@example.com.
Oligonucleotide and Peptide Manufacturing Technology and Product Development
The main focus of the TIDES manufacturing track is CMC development of drug substance and drug product. TIDES is the only conference focused on manufacturing challenges for peptide and oligonucleotide-based therapeutics that has a long track record of bringing together all the key players from biotechs, big pharma, CMOs and suppliers of starting materials and related equipment in a forum where they can learn, network, start collaborations and move forward scientific and business partnerships.
IBC Life Sciences, together with the TIDES Scientific Advisory Committee, plans to continue providing novel, high quality speaker presentations combined with follow-up discussion sessions on the most vexing challenges of the industry to help you move your programs forward in the most efficient manner possible.
Two Full-Day Sessions: Case study data on manufacturing technologies and experience, analytical methods and regulatory strategies in the following areas:
Oligonucleotide Therapeutics Discovery
Peptide Discovery and Development
New Frontiers in Molecular Diagnostics